LLMpediaThe first transparent, open encyclopedia generated by LLMs

Mahlon Hoagland

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Hamilton Township Hop 5
Expansion Funnel Raw 61 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted61
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Mahlon Hoagland
NameMahlon Hoagland
Birth dateMarch 6, 1921
Birth placeNew Bedford, Massachusetts
Death dateOctober 16, 2009
Death placeBoston, Massachusetts
NationalityAmerican
FieldsBiochemistry, Molecular biology
Alma matersHarvard College, Harvard Medical School
Known forDiscovery of transfer RNA

Mahlon Hoagland was an American biochemist and molecular biology researcher best known for his role in elucidating the function of transfer RNA in protein biosynthesis. His work at institutions such as Princeton University, Harvard Medical School, and the National Institutes of Health contributed to foundational understanding that influenced later research at Cold Spring Harbor Laboratory, the Max Planck Society, and pharmaceutical development at Merck & Co..

Early life and education

Hoagland was born in New Bedford, Massachusetts and raised in a milieu shaped by regional ties to New England and the industrial history of Whaling. He attended Harvard College for undergraduate studies and proceeded to Harvard Medical School for medical training, where he interacted with contemporaries connected to laboratories at Massachusetts General Hospital, Dana–Farber Cancer Institute, and scholars influenced by figures from the Rockefeller University and Johns Hopkins University. During World War II and the postwar era he encountered scientific networks that included investigators from the National Academy of Sciences and participants in conferences at Cold Spring Harbor Laboratory and Woods Hole Oceanographic Institution.

Career and research

Hoagland's academic appointments included positions associated with Princeton University and research affiliations at the National Institutes of Health and Boston University. He collaborated with colleagues trained at institutions like Yale University, Columbia University, and Stanford University and maintained connections with industrial research groups at Eli Lilly and Company and Pfizer. His laboratory employed biochemical approaches contemporaneous with methods developed at Carnegie Institution for Science and drew on techniques promulgated by researchers at Rockefeller Institute, Salk Institute, and Institute Pasteur. Hoagland's contemporaries and correspondents included notable scientists whose work intersected with investigations at MIT, Caltech, and University of California, Berkeley.

Working in the era following discoveries at University of Cambridge and the deciphering efforts linked to the Genetic Code problem, Hoagland contributed to the identification and functional characterization of the adapter molecules that mediate selection of amino acids during translation. This research built on experimental frameworks advanced by teams at Cambridge University, Cold Spring Harbor Laboratory, and the Max Planck Institute. The concept of an adaptor molecule had been proposed in discussions around the genetic code by investigators influenced by breakthroughs from laboratories such as those of Francis Crick and Sydney Brenner at institutions with ties to University of Cambridge. Hoagland's biochemical isolation work paralleled ribonucleic investigations at University of Chicago and enzymology studies at University of Oxford and led to empirical support for the existence of transfer RNA species that deliver specific amino acids to the ribosome during polypeptide elongation, a mechanism also examined by teams at University of California, San Francisco and Johns Hopkins University. The methodologies he and his collaborators used resonated with contemporaneous assays developed at Institut Pasteur and analytical approaches from the European Molecular Biology Laboratory.

Awards and honors

Hoagland received recognition from organizations linked to the broader scientific community, including election to bodies analogous to the National Academy of Sciences and honors reflecting contributions acknowledged by societies with associations to American Association for the Advancement of Science and award programs similar to those administered by the Lasker Foundation and the Guggenheim Fellowship network. His discoveries were cited in contexts involving retrospectives at institutions such as Cold Spring Harbor Laboratory, major symposia held at Royal Society venues, and commemorations that included participants from Harvard Medical School, MIT, and Stanford University.

Personal life and legacy

Hoagland's personal biography intersected with academic and civic institutions in Massachusetts and the broader scientific ecosystem centered on Boston and Cambridge, Massachusetts. His legacy influenced generations of researchers working at laboratories across North America, Europe, and institutions affiliated with the World Health Organization and international collaborative projects at centers such as Institut Pasteur and Max Planck Society. Posthumous discussions of his work appeared in reviews in journals associated with editorial offices linked to Nature Publishing Group, Science (journal), and specialized publications managed by societies like the American Society for Biochemistry and Molecular Biology.

Category:1921 births Category:2009 deaths Category:American biochemists